Dimethyl (2-chloromethyl-2-propenyl)phosphonate (3b) and (tert-butyl)[2-(chloromethyl)-2-propenyl](phenyl)phosphane oxide (3d) were prepared and their reactions with α,β-unsaturated esters 5a−c and ketone 5d, acting as phosphorylated trimethylenemethane equivalents by a [3+2] strategy, were investigated. With the use of LDA in the presence of DMPU, the Michael addition proceeded with high stereoselectivity and regioselectivity to afford methylenecyclopentyl-substituted dimethyl phosphonate or (tert-butyl)(phenyl)phosphane oxide derivatives 6a−d and 14(SP). Compound 3d reacted with 5a−b and 5d to give phosphorous diastereomers 10(RP) and 11(SP), 12(RP) and 13(SP), and 16(RP) and 17(SP), with complete stereoselectivity at the three stereogenic centers of the 5-methylenecyclopentanes, all possessing 1,2-trans and 2,3-trans stereochemistry. Formation of open-chain syn adduct 15 and of a 2,3-cis-disubstituted cyclopentane compound 18(SP) could also be achieved. The stereochemical features of all the products were ascertained by 1D and 2D NMR spectra.
No takes yet. Share an insight, caveat, or question.
Ruan et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: